Rich World’s Rate-Cut Momentum Is Fading Away

The final flurry of global monetary policy decisions for 2025 is likely to showcase how the easing cycle in advanced ...
International Monetary Fund

IMF Executive Board Completes the Fourth Review under the Extended Fund Facility and First Review under the Resilience and Sustainability Facility Arrangements for Jo…

The Executive Board of the International Monetary Fund (IMF) today completed the fourth review of the arrangement under the ...

Genentech’s Giredestrant Reduced Risk of Invasive Disease Recurrence or Death by 30% in ER-positive Early-Stage Breast Cancer

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive data from the Phase III lidERA Breast Cancer study evaluating investigational giredestrant as an adjuvant ...